Parkinson’s patients to receive cannabis oil in ‘pioneering’ trial to test drug’s effectiveness
| | |

Parkinson’s patients to receive cannabis oil in ‘pioneering’ trial to test drug’s effectiveness

Byangie vallejo

This article was taken from: https://inews.co.uk/news/health/parkinsons-patients-clinical-trial-cannabis-oil-813513 By Paul Gallagher Study important as more people using expensive and unregulated CBD supplements that have not been monitored for effectiveness. Parkinson’s patients will receive cannabis oil in a “pioneering” clinical trial that aims to demonstrate the benefits, safety and efficacy of the treatment to help with hallucinations and…

How to spot the early signs of Parkinson’s Disease

How to spot the early signs of Parkinson’s Disease

ByMatthew Betteridge

This article was taken from: https://www.standard.co.uk/lifestyle/health/early-signs-of-parkinsons-disease-symptoms-a3811346.html By LAURA HAMPSON How to spot the early signs of Parkinson’s Disease In the UK, one in every 500 people are affected by Parkinson’s disease. While the cause of Parkinson’s is not yet known, it is a progressive and chronic neurological disease that typically affects those aged over 55 and is caused by…

Testing tears could lead to cheap and effective Parkinson’s disease screening

Testing tears could lead to cheap and effective Parkinson’s disease screening

ByMatthew Betteridge

This article was taken from: http://www.independent.co.uk/news/health/parkinsons-disease-tears-test-screening-crying-protein-neurology-a8223491.html By Alex Matthews-King Health Correspondent Parkinson’s patients’ tears had more than five times the level of abnormal molecule which forms nerve damaging clumps A few shed tears could open up a cheap way to screen patients for Parkinson’s disease, allowing earlier diagnosis and, potentially, treatment that can delay the disease. Researchers analysing the…

First hints Parkinson’s can be stopped

First hints Parkinson’s can be stopped

ByMatthew Betteridge

It may be possible to stop the progression of Parkinson’s disease with a drug normally used in type 2 diabetes, a clinical trial suggests. Current drugs help manage the symptoms, but do not prevent brain cells dying. The trial on 62 patients, published in the Lancet, hints the medicine halted the progression of the disease….